Gilead’s Global Efforts Towards HCV Elimination by 2030: Progress and Collaboration February 16, 2024 by Mathieu Maurice Carrie Frenette, a veteran liver specialist, reflects on her patients with hepatitis C (HCV) before 2013, the watershed year when the FDA approved Gilead’s groundbreaking medicine, marking the advent of …
